您当前所在的位置:首页 > 产品中心 > 产品信息
Sunitinib Malate_分子结构_CAS_341031-54-7)
点击图片或这里关闭

Sunitinib Malate

产品号 Bio-0145 公司名称 InterBioScreen
CAS号 341031-54-7 公司网站 http://www.ibscreen.com
分子式 C26H33FN4O7 电 话 +7 49652 40091
分子量 532.5612232 传 真 +7 49652 40092
纯 度 电子邮件 screen@ibscreen.chg.ru
保 存 Chembase数据库ID: 179720

产品价格信息

请登录

产品别名

标题
Sunitinib Malate
IUPAC标准名
2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide
IUPAC传统名
2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide
别名
Sutent
sunitinib
SU-11248

产品登记号

CAS号 341031-54-7

产品性质

应用领域 Anticancer drug for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST)
成盐信息 Malate
生物活性机理 Multi-targeted receptor tyrosine kinase (RTK) inhibitor

产品详细信息

参考文献

  • Motzer RJ et al. (2007). "Sunitinib versus interferon alfa in metastatic renal-cell carcinoma". N Engl J Med 356 (2): 115?24
  • Motzer RJ et al. "Phase 3 Randomized Trial of Sunitinib malate (SU11248) versus Interferon-alfa as First-line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma".
  • Presented at ASCO 2006
  • Demetri GD et al. (2006). "Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial". Lancet 368: 1329?338
  • Miller KD et al.. "Phase II study of SU11248, a multi-targeted tyrosine kinase inhibitor in patients with previously treated metastatic breast cancer".